Related Experiment Videos
Digitoxigenin 3-O-beta-D-furanosides.
Journal of Medicinal Chemistry
|February 1, 1986
Summary
Researchers synthesized novel digitoxigenin glycosides using Koenig-Knorr condensation. These compounds, including riboside and glucoside derivatives, exhibited weak to moderate cardiotonic activity, suggesting potential therapeutic applications.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Cardiac glycosides, like digitoxigenin, are known for their cardiotonic effects.
- Developing novel analogs with modified glycosidic moieties is crucial for exploring structure-activity relationships and improving therapeutic profiles.
Purpose of the Study:
- To synthesize novel digitoxigenin glycosides with diverse sugar residues.
- To evaluate the cardiotonic activity of the synthesized compounds and their intermediates.
Main Methods:
- Koenig-Knorr condensation of acylated furanoses with digitoxigenin.
- Basic hydrolysis to remove protecting groups.
- Assessment of cardiotonic activity of synthesized compounds.
Main Results:
- Successfully synthesized four digitoxigenin glycosides: riboside, 5-amino-5-deoxyriboside, 3,6-anhydroglucoside, and 3,6-dideoxy-3,6-iminoglucoside.
- The synthesized compounds and some intermediates demonstrated weak to moderate cardiotonic activity.
Conclusions:
- The synthetic strategies employed were effective in preparing novel digitoxigenin glycosides.
- The observed cardiotonic activity suggests these novel compounds warrant further investigation for potential pharmaceutical development.